BiOS

Bios Life

Bios Life develops an AI-powered cancer surveillance and virtual care platform for cancer survivors and individuals at elevated risk of the disease.

StratifAI

This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.

Gabbi

This company develops a risk assessment platform for the early detection of breast cancer, serving individuals and corporate health benefit programmes.

Persona-Dx

The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.

Ataraxis AI

This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.

Azra

This company develops an artificial intelligence platform to automate oncology workflows and patient navigation for health systems and cancer centres.

20/20 BioLabs

This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.

Astron Health

This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.